1. Home
  2. ABBV

ABBV

AbbVie Inc.

Logo AbbVie Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 4:00pm EST

$
-
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

Founded: N/A Country:
United States
United States
Employees: N/A City: NORTH CHICAGO
Market Cap: 294.7B IPO Year: N/A
Target Price: $182.18 AVG Volume (30 days): 5.6M
Analyst Decision: Buy Number of Analysts: 12
Dividend Yield: 3.68% Dividend Payout Frequency: Quarterly
EPS: 2.72 EPS Growth: -58.97
52 Week Low/High: $130.96 - $182.89 Next Earning Date: 04-26-2024
Revenue: $54,318,000,000 Revenue Growth: -6.44%
Revenue Growth (this year): 2.46% Revenue Growth (next year): 6.15%

Share on Social Networks: